Perficient, Inc. (PRFT) Q4 2023 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call summary reveals declining financial metrics, including lower gross margins, net income, and EPS, alongside reduced operating cash flows. While management expresses optimism for a second-half recovery and discretionary spending, uncertainties remain with delays in bookings and challenging margins. The Q&A highlights persistent project ramp-up delays and unclear guidance on organic growth. Despite some positive client conversations and potential acquisitions, the overall sentiment is negative, driven by financial declines and uncertainty in future growth projections.
Key Financial Performance
Services Revenue (Q4 2023) $216.5 million, a 5% decrease year-over-year due to extended sales cycles and a shift in client buying behavior.
Services Gross Margin (Q4 2023) 37.7%, down from 40.8% year-over-year, primarily due to changes in revenue mix and cost structure.
SG&A Expense (Q4 2023) $40.3 million, down from $43.7 million year-over-year, with a decrease in SG&A expense as a percentage of revenues to 18.3% from 18.8% due to lower bonus expenses and bad debt recoveries.
Adjusted EBITDA (Q4 2023) $46.7 million or 21.1% of revenues, compared to $54.3 million or 23.4% of revenues in the prior year, reflecting lower revenue.
Net Interest Income (Q4 2023) $0.4 million, compared to $0.8 million of net interest expense in the prior year, primarily due to a $1.2 million increase in interest income from higher cash balances and interest rates.
Effective Tax Rate (Q4 2023) 29.5%, up from 28% in the prior year.
Net Income (Q4 2023) $23.2 million, down from $26.5 million in the prior year.
Diluted GAAP EPS (Q4 2023) $0.65, down from $0.74 in the prior year.
Adjusted EPS (Q4 2023) $0.99, down from $1.14 in the prior year.
Services Revenue (Full Year 2023) $892.9 million, essentially flat compared to the prior year.
Services Gross Margin (Full Year 2023) 38%, down from 40.2% in the prior year.
SG&A Expense (Full Year 2023) $170.6 million, slightly down from $171.1 million in the prior year, with SG&A as a percentage of revenues decreasing to 18.8% from 18.9%.
Adjusted EBITDA (Full Year 2023) $190.7 million or 21.4% of revenues, down from $205.8 million or 22.2% of revenues in the prior year.
Net Interest Expense (Full Year 2023) $0.4 million, down from $3.2 million in the prior year, primarily due to a $2.7 million increase in interest income.
Effective Tax Rate (Full Year 2023) 27.5%, up from 25.9% in the prior year, due to a decrease in research credit benefit and an increase in stock compensation impact.
Net Income (Full Year 2023) $98.9 million, down from $104.4 million in the prior year.
Diluted GAAP EPS (Full Year 2023) $2.76, down from $2.90 in the prior year.
Adjusted EPS (Full Year 2023) $3.95, down from $4.28 in the prior year.
Operating Cash Flows (Full Year 2023) $103 million, down from $118.1 million in the prior year, primarily due to increased cash inflows related to accounts receivable.
Outstanding Debt (as of December 31, 2023) $396.9 million.
Cash and Cash Equivalents (as of December 31, 2023) $128.9 million.
Unused Borrowing Capacity (as of December 31, 2023) $300 million.
Operating Highlights
AI Capabilities: Perficient is engaged in delivering significant usable AI projects, including applications for personalized responses based on customer intent and natural language analytics.
PACE Framework: Launched in January, the PACE framework provides a holistic approach to responsibly operationalizing AI across organizations.
Envision Online Platform: The business capability library module has grown to over 700 defined capabilities, with new capabilities introduced for various disciplines.
Acquisition of SMEDIX: Perficient completed the acquisition of SMEDIX, enhancing its capabilities in healthcare and life sciences.
Global Expansion: Romania is intended to become Perficient's hub in Europe, replicating the success established in India and Latin America.
Bookings Growth: Q4 bookings were up nearly double digits year-over-year, driven by larger deals, with 56 deals greater than $1 million booked.
Billable Headcount: Nearly 60% of Perficient's billable headcount is now located outside the United States.
Operational Cash Flows: Operating cash flows increased to $103 million in 2023 from $118.1 million in the prior year.
Focus on AI: Clients across various verticals are expressing strong interest in Perficient's AI capabilities, which have been developed over nearly a decade.
Diversification: Perficient remains well-diversified across customer, industry, and platform perspectives, with strong verticals in healthcare and financial services.
Risk or Challenges
Sales Cycle Challenges: The second half of 2023 experienced extended sales cycles and a shift in client buying behavior, which posed challenges for the company.
Regulatory Risks: The company is engaged in healthcare and life sciences, which are heavily regulated industries, potentially exposing it to compliance risks.
Supply Chain Issues: The company has a significant portion of its workforce based outside the U.S., which may introduce supply chain challenges related to talent acquisition and management.
Economic Factors: The overall economic environment may impact client spending and investment in digital transformation initiatives.
Competitive Pressures: The company faces competition in the healthcare and life sciences sectors, particularly as it expands its capabilities in AI and digital transformation.
Tax Rate Increases: The effective tax rate increased from 25.9% to 27.5%, which could affect net income and cash flow.
Earnings Decline: Net income decreased from $104.4 million to $98.9 million, indicating potential profitability challenges.
Margin Compression: Gross margin decreased from 40.2% to 38%, reflecting pressures on profitability.
Guidance & Outlook
Acquisition of SMEDIX: Completed acquisition of SMEDIX, enhancing capabilities in healthcare and life sciences.
Global Expansion: Plans to establish Romania as a European hub, replicating successful models from India and Latin America.
Bookings Growth: Q4 bookings increased nearly double digits year-over-year, with 56 deals over $1 million.
AI Initiatives: Engagement in AI projects, including generative AI capabilities for clients, particularly in healthcare.
PACE Framework: Launched PACE framework for responsible AI operationalization.
Envision Platform Development: Continued progress on the Envision platform, expanding capabilities and vendor options.
Employee Resource Group Launch: Launched LiveWell, a resource group focused on colleague well-being.
Q1 2024 Revenue Guidance: Expected revenue range of $212 million to $218 million.
Q1 2024 GAAP EPS Guidance: Expected GAAP EPS range of $0.31 to $0.35.
Q1 2024 Adjusted EPS Guidance: Expected adjusted EPS range of $0.74 to $0.79.
Full Year 2024 Revenue Guidance: Expected revenue range of $925 million to $965 million.
Full Year 2024 GAAP EPS Guidance: Expected GAAP EPS range of $2.64 to $2.77.
Full Year 2024 Adjusted EPS Guidance: Expected adjusted EPS range of $4.05 to $4.20.
Shareholder Return Plan
Share Repurchase Program: Perficient has not announced any share repurchase program during the call.
Key Q&A
Earnings Word Cloud
PRFT Transcript
The earnings call summary reveals declining financial metrics, including lower gross margins, net income, and EPS, alongside reduced operating cash flows. While management expresses optimism for a second-half recovery and discretionary spending, uncertainties remain with delays in bookings and challenging margins. The Q&A highlights persistent project ramp-up delays and unclear guidance on organic growth. Despite some positive client conversations and potential acquisitions, the overall sentiment is negative, driven by financial declines and uncertainty in future growth projections.
PRFT Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
